Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antibiotic/atrofija

Povezava se shrani v odložišče
Stran 1 iz 20 rezultatov

Antibiotic treatment of age-related macular degeneration

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
TABLE OF CONTENTS 1. BACKGROUND OF THE INVENTION 1.1 TECHNICAL FIELD 1.2 BACKGROUND OF ART 2. SUMMARY OF THE INVENTION 3. BRIEF DESCRIPTION OF THE DRAWINGS 4. DESCRIPTION OF PREFERRED EMBODIMENTS 5. CLAIMS 6. ABSTRACT OF THE DISCLOSURE 7. DRAWING 8. DECLARATION AND POWER OF ATTORNEY 9. DECLARATION

Antibiotic treatment of age-related macular degeneration

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
TABLE OF CONTENTS 1. BACKGROUND OF THE INVENTION 1.1 TECHNICAL FIELD 1.2 BACKGROUND OF ART 2. SUMMARY OF THE INVENTION 3. BRIEF DESCRIPTION OF THE DRAWINGS 4. DESCRIPTION OF PREFERRED EMBODIMENTS 5. CLAIMS 6. ABSTRACT OF THE DISCLOSURE 7. DRAWING 8. DECLARATION AND POWER OF ATTORNEY 9. DECLARATION
BACKGROUND OF THE INVENTION 1) Field of the Invention The present invention relates to novel lactic acid bacteria belonging to the genus Streptococcus salivarius subsp. thermophilus and variants thereof. This invention is also concerned with a novel antibacterial substance produced by the above
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel lactic acid bacteria belonging to the genus Streptococcus salivarius subsp. thermophilus and variants thereof. This invention is also concerned with a novel antibacterial substance produced by the above

Treatment and prevention of Th1 and `autoimmune` diseases effected with antibiotics and/or angiotensin inhibition

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF INVENTION It is currently believed that the diseases known as "autoimmune" diseases are caused by the body's immune system attacking the body itself. But I have discovered that these so-called "autoimmune" diseases are actually caused by stealthy intra-cellular bacteria. I have

Synthetic ligation reassembly in directed evolution

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION This invention relates to the field of protein engineering. Specifically, this invention relates to a directed evolution method for preparing a polynucleotide encoding a polypeptide. More specifically, this invention relates to a method of using mutagenesis to generate a novel

Synthetic ligation reassembly in directed evolution

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION This invention relates to the field of protein engineering. Specifically, this invention relates to a directed evolution method for preparing a polynucleotide encoding a polypeptide. More specifically, this invention relates to a method of using mutagenesis to generate a novel

Dental composition containing organic nanotube

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION The present invention relates to a dental composition containing an organic nanotube. More specifically, the present invention relates to a dental composition comprising: unsaturated double bond-containing monomers and/or oligomers; a catalytic amount of polymerization

Method for the delivery of compositions to the ocular tissues

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to a method for delivery of compositions to the ocular tissues and, more particularly, to a method for delivering compositions to the ocular tissues in sufficient quantity without toxic effects. Description of the

Composite semipermeable membrane and process for producing the same

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION The present invention relates to a composite semipermeable membrane having a skin layer which includes a polyamide resin and a porous support that supports the skin layer, and to a process for producing the composite semipermeable membrane. The composite semipermeable
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to methods and pharmaceutical compositions for administering therapeutic cells to the upper third of the nasal cavity of a mammal, thereby enabling the therapeutic cells to bypass the blood-brain barrier to
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to methods and pharmaceutical compositions for administering therapeutic cells to the upper third of the nasal cavity of a mammal, thereby enabling the therapeutic cells to bypass the blood-brain barrier to

Heterocyclic substituted-amino-pyrazolines

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION R. Battisti, et al., U.S. Pat. No. 4,149,005 (Apr. 10, 1979) discloses compounds of the formula: ##STR1## where R is H or CH.sub.3, X is H, Br, Cl, alkyl, alkoxy or carboxyalkyl groups with from 1 to 4 carbon atoms or CF.sub.3 ; and n is 1 or 2. These are disclosed as

Therapeutically active 3-substituted amino-1-phenyl and substituted phenyl-2-pyrazolines

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
PRIOR ART 1. R. Battisti, et. al., U.S. Pat. No. 4,149,005 (Apr. 10, 1979) discloses compounds of the formula: ##STR1## where R is H or CH.sub.3, X is H, Br, Cl, alkyl, alkoxy or carboxyalkyl groups with from 1 to 4 carbon atoms or CF.sub.3 ; and n is 1 or 2. These are disclosed as being used as

3-Trifluoroacetylamino-1-aryl-2-pyrazolines

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
PRIOR ART 1. R. Battisti, et. al., U.S. Pat. No. 4,149,005 (Apr. 10, 1979) discloses compounds of the formula: ##STR1## where R is H or CH.sub.3, X is H, Br, Cl, alkyl, alkoxy or carboxyalkyl groups with from 1 to 4 carbon atoms or CF.sub.3 ; and n is 1 or 2. These are disclosed as being used as
Pridružite se naši
facebook strani

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

  • Deluje v 55 jezikih
  • Zeliščna zdravila, podprta z znanostjo
  • Prepoznavanje zelišč po sliki
  • Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
  • Preberite znanstvene publikacije, povezane z vašim iskanjem
  • Iščite zdravilna zelišča po njihovih učinkih
  • Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah

Google Play badgeApp Store badge